ArtNr |
TRC-B682600-100mg |
Hersteller |
Toronto Research Chemicals
|
CAS-Nr. |
22260-51-1 |
Menge |
100 mg |
Quantity options |
100 mg
10 mg
250 mg
25 mg
500 mg
50 mg
|
Kategorie |
|
Typ |
Biochemicals |
Specific against |
other |
Purity |
>95% (HPLC) |
InCHI |
1S/C32H40BrN5O5.CH4O3S/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18;1-5(2,3)4/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39);1H3,(H,2,3,4)/t18-, |
Smiles |
CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C.CS(=O)(=O)O |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Bromocriptine mesilate, (6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide monomethanesulfonate, Ergocryptine, 2-bromo-, monomethanesulfonate (salt) (8CI), 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv., Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv., (+)-Bromocriptine methanesulfonate, Bagren, Bromocriptine mesylate, Bromocriptine methanesulfonate, Bromocryptine mesylate, Bromocryptine methanesulfonate, CB 154, Cycloset, Parlodel, Pravidel, Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5alpha)-, methanesulfonate (1:1), Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-, monomethanesulfonate (salt) (9CI) |
Versandbedingung |
Raumtemperatur |
Gefahren-Info |
Shipping Info: Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package | Air Forbidden: False | Controlled Products: Not Controlled | Hazardous Class: Suspected of damaging fertility or the unborn child | UN #: UN3077 | IATA Regulations: 9 | Packing Group: III |
Lieferbar |
|
Manufacturer - Category |
Impurity standards; Additional pharmaceutical toxicology reference materials; Enzyme inhibitors; Alkaloids; Additional pharmaceutical toxicology research materials; Dopamine receptors; Addiction; Alzheimer's; Depression; Huntington's; Neurotransmission; Parkinson's; Schizophrenia; Stress and Anxiety; Pain and Inflammation; Additional toxicology reference materials; Neurological diseases (Alzheimer's, Parkinson's, Dementia) |
Country of Origin |
Canada |
Shipping Temperature |
RT|Room Temperature |
Storage Conditions |
-20°C |
Molecular Weight |
750, 7 |
Shipping Info |
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
Air Forbidden |
False |
Controlled Products |
Not Controlled |
MSDS Availability |
TRUE |
Hazardous Class |
Suspected of damaging fertility or the unborn child |
UN # |
UN3077 |
IUPAC |
(6aR, 9R)-5-Bromo-N-[(2R, 5S, 10aS, 10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3, 6-dioxooctahydro-8H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl]-7-methyl-4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinoline-9-carboxamide methanesulfonate |
IATA Regulations |
9 |
Packing Group |
III |
Manufacturer - Synonym |
Bromocriptine mesilate, (6aR, 9R)-5-Bromo-N-[(2R, 5S, 10aS, 10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3, 6-dioxooctahydro-8H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl]-7-methyl-4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinoline-9-carboxamide monomethanesulfonate, Ergocryptine, 2-bromo-, monomethanesulfonate (salt) (8CI), 8H-Oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazine, ergotaman-3', 6', 18-trione deriv., Indolo[4, 3-fg]quinoline, ergotaman-3', 6', 18-trione deriv., (+)-Bromocriptine methanesulfonate, Bagren, Bromocriptine mesylate, Bromocriptine methanesulfonate, Bromocryptine mesylate, Bromocryptine methanesulfonate, CB 154, Cycloset, Parlodel, Pravidel, Ergotaman-3', 6', 18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5alpha)-, methanesulfonate (1:1), Ergotaman-3', 6', 18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-, monomethanesulfonate (salt) (9CI) |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.